Communicating non-steroidal anti-inflammatory drug risks: Verbal counseling, written medicine information, and patients’ risk awareness

Schmitt, Michael R.; Miller, Michael J.; Harrison, Donald L.; Farmer, Kevin C.; Allison, Jeroan J.; Cobaugh, Daniel J.; Saag, Kenneth G.

doi:10.1016/j.pec.2010.10.032

Cited by 38 publications

(52 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…114,118 According to a recent survey, a large number of patients report not having received counseling about risks of NSAIDs from either a physician or a pharmacist. 113 Unbeknownst to the clinician, patients may engage in independent self-care with nonprescription NSAIDs but may not know about the potential harms, particularly with multiple NSAID use. 31, Further complicating matters, NSAIDs are being used unnecessarily.…”

Section: Guidelines For the Prevention Of Nsaid-associated Risksmentioning

confidence: 99%

NSAIDs for Musculoskeletal Pain Management: Current Perspectives and Novel Strategies to Improve Safety

Atchison¹,

Herndon²,

Rusie³

2013

JMCP

View full text Add to dashboard Cite

and completed residency training in physical medicine and rehabilitation at The Ohio State University. Dr. Atchison has been in practice at academic medical centers for more than 20 years, serving on the faculty at the University of Kentucky and University of Florida before his appointment at Northwestern University. A recognized teacher and researcher in the field of pain management and rehabilitation, he has presented courses, lectures, and workshops nationally and internationally on pharmacological and nonpharmacological therapies, care of spinal injuries, and spinal manipulation. Dr. Atchison has led and participated in many research projects, including several funded by the National Institutes of Health. He has authored numerous research papers and book chapters, and he serves as a peer reviewer for the Archives of Physical Medicine and Rehabilitation. He has been a member of the editorial boards of the Supplement Policy Statement Standards for Supplements to the Journal of Managed Care PharmacySupplements to the Journal of Managed Care Pharmacy are intended to support medical education and research in areas of clinical practice, health care quality improvement, or efficient administration and delivery of health benefits. The following standards are applied to all JMCP supplements to ensure quality and assist readers in evaluating potential bias and determining alternate explanations for findings and results. 1. Disclose the principal sources of funding in a manner that permits easy recognition by the reader. 2. Disclose the existence of all potential conflicts of interest among supplement contributors, including financial or personal bias. 3. Describe all drugs by generic name unless the use of the brand name is necessary to reduce the opportunity for confusion among readers. 4. Identify any off-label (unapproved) use by drug name and specific off-label indication. 5. Strive to report subjects of current interest to managed care pharmacists and other managed care professionals. S14 Multitarget Drugs S15 Conclusions S15 References Target AudiencesThis CME/CE activity is designed to meet the educational needs of pharmacists, physicians, nurse practitioners, and nurses. Learning Objectives• Assess patient-specific risk factors in selecting NSAIDs for mild-to-moderate musculoskeletal pain • Incorporate risk/benefit analysis in decision making about NSAID use • Use evidence-based guidelines for selecting NSAID therapy and applying strategies to prevent complications • Evaluate the efficacy, safety, and pharmacological profile of new and emerging NSAID formulations Funding This supplement was funded by an independent educational grant to PRIME Education, Inc. (PRIME) from Iroko Pharmaceuticals, LLC. Accreditation StatementsIn support of improving patient care, PRIME Education, Inc. (PRIME) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing educat...

show abstract

Section: Guidelines For the Prevention Of Nsaid-associated Risksmentioning

confidence: 99%

NSAIDs for Musculoskeletal Pain Management: Current Perspectives and Novel Strategies to Improve Safety

Atchison¹,

Herndon²,

Rusie³

2013

JMCP

View full text Add to dashboard Cite

show abstract

“…24 Published research has demonstrated that physician risk counseling is a strong, positive predictor of NSAID risk awareness. 25 Therefore, the point of prescribing provides an opportunity for physicians to ascertain and evaluate patient risk knowledge and to properly communicate accurate risk information. Formerly testing for health literacy in a clinical practice setting is not a recommended practice because shame associated with inadequate health literacy may adversely affect patient interaction and engagement with the health care provider.…”

mentioning

confidence: 99%

Screening Questions for Nonsteroidal Anti-inflammatory Drug Risk Knowledge

Bogert¹,

Miller²,

Cobaugh³

et al. 2017

J Patient Saf

Self Cite

View full text Add to dashboard Cite

OBJECTIVE: The aim of this study was to evaluate screening questions for estimating nonsteroidal anti-inflammatory drug (NSAID) risk knowledge. METHODS: Cross-sectional data from a telephone interview of NSAID users 50 years or older from 39 physician practices in Alabama were used. Patient-reported awareness of prescription NSAID risk and health literacy were the independent variables, and a cumulative index score of objectively tested knowledge of 4 prominent NSAID risks was the dependent variable. General linearized latent and mixed model ordered logistic regression was used to estimate associations among the independent variables, covariates, and objectively tested NSAID risk knowledge. Population-averaged probabilities for levels of objectively tested NSAID risk knowledge were subsequently estimated. RESULTS: Subjective awareness of any prescription NSAID risk (adjusted odds ratio [AOR], 2.40; 95% confidence interval [CI], 1.55-3.74), adequate health literacy (AOR, 1.71; 95% CI, 1.04-2.83), and physician counseling about 1 or more NSAID risks (AOR, 1.69; 95% CI, 1.09-2.61) were significantly and positively associated with NSAID risk knowledge. The probability of correctly answering at least 1 of the 4 NSAID risk knowledge questions was 70% in the absence of any subjective risk awareness and in less than adequate health literacy. Whereas the probability of correctly answering at least 1 of the 4 NSAID risk knowledge questions increased to 86% in the presence of subjective awareness of any prescription NSAID risk and adequate health literacy. CONCLUSIONS: Screening questions for subjective NSAID risk awareness and health literacy are predictive of objectively tested NSAID knowledge and can be used to triage patients as well as subsequently initiate and direct a conversation about NSAID risk

show abstract

“…In The Netherlands, one study showed that 66% of patients perceived the prescribing clinician to be the primary source of information about their medication [16]. Additionally, clinician counseling regarding risks generates higher patient awareness than pharmacist counseling or written educational materials [17]. Studies show that patients struggle with reading drug labels and provided instructions [18,19].…”

Section: Introductionmentioning

confidence: 99%

The practice of prescribing: Discovering differences in what we tell patients about prescription medications

Childress

Ledford

Mundy

2014

Patient Education and Counseling

View full text Add to dashboard Cite

Communicating non-steroidal anti-inflammatory drug risks: Verbal counseling, written medicine information, and patients’ risk awareness

Cited by 38 publications

References 27 publications

NSAIDs for Musculoskeletal Pain Management: Current Perspectives and Novel Strategies to Improve Safety

NSAIDs for Musculoskeletal Pain Management: Current Perspectives and Novel Strategies to Improve Safety

Screening Questions for Nonsteroidal Anti-inflammatory Drug Risk Knowledge

The practice of prescribing: Discovering differences in what we tell patients about prescription medications

Contact Info

Product

Resources

About